Skip to content

MARLIN: A stratified, Multi-ARm, muLti-site randomised platform trial aiming to reduce the INcidence of post-operative SSI

A stratified, Multi-ARm, muLti-site randomised platform trial aiming to reduce the INcidence of post-operative SSI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202407810125318
Enrollment
10092
Registered
2024-07-01
Start date
2024-09-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Interventions

Chlorhexidine Gluconate preoperative shower
Topical wound wash before closure
Standard intraoperative care
Dialkylcarbamoyl chloride DACC wound dressing
Standard postoperative wound management

Sponsors

The University of Birmingham
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patients with at least one abdominal incision that is =5cm (open or laparoscopic extraction site), with an anticipated clean-contaminated, contaminated, or dirty surgical wound. Definitions and examples of contamination are given in Table 1. - Patients undergoing emergency (surgery on an unplanned admission) or elective (surgery on a planned admission) operations. - Any operative indication for abdominal surgery (excluding caesarean section; see exclusion criteria). - Patient able and willing to provide written informed consent (signature or a fingerprint) prior to surgery (including emergency cases). - Patients aged XX years and over. (This criteria MUST be made country-specific. Each country will decide the lower (and upper, if applicable according to local regulations age limit for the trial. This will be dependent on country-specific regulatory approvals. Age eligibility will vary by country. The lowest possible age of eligibility is 5 years old in all territories.)

Exclusion criteria

Exclusion criteria: - Patient unable to complete post-operative follow-up (i.e., will not be contactable after discharge). - Patients undergoing clean surgical procedures. - Patients undergoing an obstetrics procedure, including caesarean sections.

Design outcomes

Primary

MeasureTime frame
Surgical site infection within 30-days after surgery

Secondary

MeasureTime frame
SSI at or prior to discharge from hospital ;Mortality (and likely cause);Length of hospital stay for index admission ;Readmission;Return to normal activities (e.g. work, school, or family duties) ;Unplanned wound opening ;Re-operation for SSI

Countries

Benin, Rwanda

Contacts

Public ContactRachel Lillywhite

Trials Management Team Leader

r.e.lillywhite@bham.ac.uk447514800721

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026